With patients as their guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by HAE and rare and niche allergic and immunological diseases.


Biotechnology

Pharmaceutical

Astria Therapeutics

Astria Therapeutics' headquarters in Cambridge, MA, United States

Jill C. Milne

Andrew A. Komjathy

Keri McGrail

Christopher Morabito

Paige Huggon

Matt Maderos

Ben Harshbarger

Rafif Dagher

John Ruesch

Noah Clauser

Harison C. Hong

Michele Gunsior

Anne-Elise Tobin

Laura Asinas Blackburn

Andrea Matthews

Gregg Lapointe

Michael D. Kishbauch

Kenneth Bate

Joanne T. Beck

Fred Callori

Hugh M. Cole

Jonathan Violin

This department oversees early clinical development, regulatory compliance, and medical affairs to ensure the safe and effective progression of drug products.

Clinical and Regulatory Affairs

The Legal and Governance team at Astria Therapeutics is responsible for overseeing the company's legal affairs and ensuring compliance with regulatory requirements. This team, composed of seasoned legal professionals and board members, advises on corporate governance, navigates legal risks, and ensures that the company operates in alignment with ethical standards, thereby supporting its mission to deliver innovative therapies for patients with HAE and rare diseases.

Legal and Governance

The Leadership Team at Astria Therapeutics is responsible for setting the strategic direction and operational oversight of the company. Comprising experts in corporate affairs, science, finance, commercial strategy, and legal matters, the team works collaboratively to drive innovation, ensure regulatory compliance, and deliver patient-centered therapies that address unmet medical needs in rare and niche allergic and immunological diseases. Their collective expertise guides the company's mission of transforming the lives of patients and families with HAE and related conditions.

Leadership Team

This department oversees the planning, execution, and management of clinical trials to ensure compliance and efficiency.

Clinical Operations

The Research and Development team at Astria Therapeutics focuses on innovating and advancing therapies for hereditary angioedema (HAE) and rare allergic and immunological diseases. Comprised of experts in chemistry, biology, and antibody discovery, the team collaborates to design, develop, and optimize potential treatments, ensuring their safety and efficacy for patients. Each member plays a crucial role in driving scientific excellence and pushing the boundaries of therapeutic innovation.

Research and Development

The Clinical Operations Team at Astria Therapeutics is responsible for overseeing the planning, execution, and management of clinical trials to ensure the safety and efficacy of new therapies. This team collaborates with cross-functional partners to streamline processes, maintain regulatory compliance, and optimize patient engagement, all while focusing on the unique needs of individuals affected by rare and niche allergic and immunological diseases. Through their expertise, they play a crucial role in bringing innovative treatments from the research phase to market, ultimately enhancing patient outcomes.

Astria Therapeutics

Org chart

Board & advisors

Teams

Clinical and Regulatory Affairs

Legal and Governance

Leadership Team

Clinical Operations

Research and Development

Clinical Operations Team

Offices

Astria Therapeutics

Org chart

Board & advisors

Teams

Clinical and Regulatory Affairs

Legal and Governance

Leadership Team

Clinical Operations

Research and Development

Clinical Operations Team

Offices

Related companies